Organigram Holdings [OGI] vs Zoetis [ZTS] Detailed Stock Comparison

Organigram Holdings Inc.

NASDAQ
Loading...

Zoetis Inc.

NYSE
Loading...

TLDR: Quick Comparison Summary

Based on 21 vital metrics comparison: Organigram Holdings Inc. wins in 6 metrics, Zoetis Inc. wins in 12 metrics, with 0 ties. Zoetis Inc. appears stronger overall.

View Metrics Details

Vital Metrics Comparison

Metric Organigram Holdings Inc. Zoetis Inc. Better
P/E Ratio (TTM) 13.05 19.58 Organigram Holdings Inc.
Price-to-Book Ratio 0.72 15.04 Organigram Holdings Inc.
Debt-to-Equity Ratio 1.99 279.59 Organigram Holdings Inc.
PEG Ratio -0.08 2.81 Zoetis Inc.
EV/EBITDA 45.83 13.96 Zoetis Inc.
Profit Margin (TTM) 6.49% 28.24% Zoetis Inc.
Operating Margin (TTM) -5.38% 34.69% Zoetis Inc.
EBITDA Margin (TTM) N/A 34.69% N/A
Return on Equity 4.64% 65.99% Zoetis Inc.
Return on Assets (TTM) -1.48% 15.26% Zoetis Inc.
Free Cash Flow (TTM) $-24.64M $2.28B Zoetis Inc.
Dividend Yield N/A 1.21% N/A
1-Year Return -24.29% -51.58% Organigram Holdings Inc.
Price-to-Sales Ratio (TTM) 0.72 5.26 Organigram Holdings Inc.
Enterprise Value $182.10M $56.75B Zoetis Inc.
EV/Revenue Ratio 0.89 6.00 Organigram Holdings Inc.
Gross Profit Margin (TTM) 36.69% 70.17% Zoetis Inc.
Revenue per Share (TTM) $2 $21 Zoetis Inc.
Earnings per Share (Diluted) $0.11 $6.02 Zoetis Inc.
Beta (Stock Volatility) 1.87 0.97 Zoetis Inc.
Short % of Float N/A 4.06% N/A

Organigram Holdings Inc. vs Zoetis Inc. Stock Performance Analysis

Loading Price Chart...

OGI
ZTS

Performance Comparison

Short-term Returns

Stock1D1W1M3M6MYTD
Organigram Holdings Inc.-2.83%-3.74%-3.74%-27.46%-42.78%-40.46%
Zoetis Inc.1.51%0.16%3.42%-31.08%-32.94%-36.81%

Long-term Returns

Stock1Y3Y5Y10Y15Y20Y
Organigram Holdings Inc.-24.29%-39.77%-90.89%-96.46%-96.46%-96.46%
Zoetis Inc.-51.58%-53.40%-57.08%71.34%156.59%156.59%

Performance & Financial Health Analysis: Organigram Holdings Inc. vs Zoetis Inc.

MetricOGIZTS
Market Information
Market Cap i$203.22M$49.75B
Market Cap CategoryMicro capLarge cap
10 Day Avg. Volume i905,9662,727,710
90 Day Avg. Volume i599,4853,835,940
Last Close$1.03$167.10
52 Week Range$1.02 - $2.24$139.70 - $200.33
% from 52W High-54.02%-16.59%
All-Time High$33.76 (May 20, 2019)$249.27 (Dec 27, 2021)
% from All-Time High-96.95%-32.96%
Growth Metrics
Quarterly Revenue Growth0.49%0.03%
Quarterly Earnings Growth1.03%0.04%
Financial Health
Profit Margin (TTM) i0.06%0.28%
Operating Margin (TTM) i-0.05%0.35%
Return on Equity (TTM) i0.05%0.66%
Debt to Equity (MRQ) i1.99279.59
Cash & Liquidity
Book Value per Share (MRQ)$1.99$7.84
Cash per Share (MRQ)$0.06$5.48
Operating Cash Flow (TTM) i$-14,204,965$2.90B
Levered Free Cash Flow (TTM) i$-28,965,085$1.79B
Dividends
Last 12-Month Dividend Yield iN/A1.21%
Last 12-Month Dividend iN/A$2.03

Valuation & Enterprise Metrics Analysis: Organigram Holdings Inc. vs Zoetis Inc.

MetricOGI (Apr 26, 2026)ZTS (Apr 13, 2026)
Price Ratios
P/E Ratio (TTM) i13.0519.58
Forward P/E i79.7215.61
PEG Ratio i-0.082.81
Price to Sales (TTM) i0.725.26
Price to Book (MRQ) i0.7215.04
Market Capitalization
Market Capitalization i$203.22M$49.75B
Enterprise Value i$182.10M$56.75B
Enterprise Value Metrics
Enterprise to Revenue i0.896.00
Enterprise to EBITDA i45.8313.96
Risk & Other Metrics
Beta i1.870.97
Book Value per Share (MRQ) i$1.99$7.84

Financial Statements Comparison: Organigram Holdings Inc. vs Zoetis Inc.

Financial Metrics

Loading Financial Charts...

Revenue

Operating Margin

Profit Margin

Long Term Debt

Income Flow Analysis

Financial Statements Comparison

Income Statement

MetricOGI (2025)ZTS (2025)
Revenue/Sales i259.18M9.47B
Cost of Goods Sold i168.97M2.67B
COGS % of Revenue i65.2%28.2%
Gross Profit i90.22M6.80B
Gross Margin i34.8%71.8%
Research & Development i10.95M698.00M
Operating Income (EBIT) i-15.30M3.60B
Operating Margin i-5.9%38.0%
EBITDA i25.88M4.17B
EBITDA Margin i10.0%44.1%
Pre-Tax Income i-38.53M3.36B
Pre-Tax Income % of Revenue i-14.9%35.5%
Income Tax i-13.77M687.00M
Income Tax % of Revenue i-5.3%7.3%
Net Income (Profit) i-24.76M2.67B
Profit Margin i-9.6%28.2%

Balance Sheet & Liquidity Metrics

MetricOGI (2025)ZTS (2025)
Cash & Equivalents i28.20M2.31B
Total Current Assets i284.90M6.77B
Total Current Assets % of Revenue i109.9%71.5%
Total Current Liabilities i126.16M2.24B
Total Current Liabilities % of Revenue i48.7%23.6%
Long-Term Debt i7.75M9.24B
Long-Term Debt % of Revenue i3.0%97.6%
Total Shareholders Equity i349.13M3.33B
Retained Earnings i-608.73M13.74B
Retained Earnings % of Revenue i-234.9%145.2%
Property, Plant & Equipment i213.60M288.00M

Cash Flow Statement Comparison

MetricOGI (2025)ZTS (2025)
Operating Cash Flow i-47.08M2.78B
Operating Cash Flow % of Revenue i-18.2%29.3%
Capital Expenditures i-16.91MN/A
Free Cash Flow i-24.64M2.28B
FCF Margin i-9.5%24.1%
Debt Repayment i-1.85M-1.35B
Common Stock Repurchase iN/A-3.24B

Short Interest & Institutional Ownership Analysis

MetricOGIZTS
Shares Short i3.36M15.12M
Short Ratio i6.853.60
Short % of Float iN/A4.06%
Shares Outstanding i135.13M424.93M
Float Shares i94.26M421.29M
% Held by Insiders i31.22%0.15%
% Held by Institutions i8.89%101.50%
% Held by Public i59.89%-1.65%

Dividend Analysis & Yield Comparison: Organigram Holdings Inc. vs Zoetis Inc.

MetricOGIZTS
Last 12-Month Dividend iN/A$2.03
Last 12-Month Dividend Yield iN/A1.21%
3-Year Avg Annual Dividend iN/A$1.80
3-Year Avg Dividend Yield iN/A0.29%
3-Year Total Dividends iN/A$5.39
Ex-Dividend DateN/AJan 20, 2026